Endocrinology and Metabolism in the Elderly

  • Uriel S. Barzel
  • Steven R. Gambert
  • Panayiotis D. Tsitouras


A widowed woman of 63 who had been living alone was visiting her daughter in the suburbs one day in the spring. She went out with her grandchild to jump rope. On her second jump, she developed severe back pain—collapse fracture of a vertebra—which immobilized her for some 3 weeks. She stayed in her daughter’s house during this time, and later, when the pain began to subside, returned to her own apartment. Eventually, she was able to resume her previous way of life.


Postmenopausal Woman Thyroid Hormone Sexual Activity Endometrial Cancer Endometrial Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barzel, U. S. (ed.), 1970, Osteoporosis, Grune and Stratton, New York.Google Scholar
  2. 2.
    Barzel, U. S. (ed.), 1979, Osteoporosis II, Grune and Stratton, New York.Google Scholar
  3. 3.
    DeLuca, H. F., Frost, H. M., Jee, W. S., Johnston, C. C., Jr., and Parfitt, A. M. (eds.), 1980, Osteoporosis: Recent Advances in Pathogenesis and Treatment, University Park Press, Baltimore.Google Scholar
  4. 4.
    Raisz, L. G., 1977, Bone metabolism and calcium regulation, in: Metabolic Bone Disease, Volume 1 (L. V. Avioli and S. M. Krane, eds.), Academic Press, New York, pp. 1–48.Google Scholar
  5. 5.
    Avioli, L. V. and Raisz, L. G., 1980, Bone metabolism and disease, in: Metabolic Control and Disease, 8th ed. (P. K. Bondy and L. E. Rosenberg, eds.), W. B. Saunders, Philadelphia, pp. 1709–1814.Google Scholar
  6. 6.
    Parfitt, A. M., 1979, Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis, Calcif. Tissue Int. 28:1–5.PubMedGoogle Scholar
  7. 7.
    Meunier, P. J., Courpron, P., Edouard, C., Alexandre, C., Bressot, C., Lips, P., and Boyce, B. F., 1979, Bone histomorphometry in osteoporotic states, in: Osteoporosis II (U. S. Barzel, ed.), Grune and Stratton, New York, pp. 27–48.Google Scholar
  8. 8.
    Teitelbaum, S. L., Rosenberg, E. M., Richardson, C. A., and Avioli, L. V., 1976, Histological studies of bone from normocalcemic postmenopausal osteoporotic patients with increased circulating parathyroid, J. Clin. Endocrinol. Metab. 42:537–543.PubMedGoogle Scholar
  9. 9.
    Gallagher, J. C., Riggs, B. L., Jerpbak, M., and Arnaud, C. D., 1980, The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women, J. Lab. Clin. Med. 95:373.PubMedGoogle Scholar
  10. 10.
    Avioli, L. V., McDonald, J. E., and Lee, S. W., 1965, The influence of age on the intestinal absorption of 47Ca in women and its relation to 47Ca absorption in postmenopausal osteoporosis, J. Clin. Invest. 44:1960–1967.PubMedGoogle Scholar
  11. 11.
    Alevizaki, C. C., Ikkos, D. C., and Singuelakis, P., 1973, Progressive decrease of true intestinal calcium absorption with age in normal man, J. Nucl. Med. 14:760–762.PubMedGoogle Scholar
  12. 12.
    Bullamore, J. R., Wilkinson, R., Gallagher, J. C., Nordin, B. E. C., and Marshall, D. H., 1970, Effects of age on calcium absorption, Lancet ii:535–537.Google Scholar
  13. 13.
    Gallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B., and DeLuca, H. F., 1979, Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients, J. Clin. Invest. 64:729–736.PubMedGoogle Scholar
  14. 14.
    Matkovic, V., Kostial, K., Siminovic, I., Brodarec, A., and Buzina, R., 1977, Influence of calcium intake, age and sex on bone, Calcil. Tissue Res. 22(Suppl):393–396.Google Scholar
  15. 15.
    Nordin, B. E. C., 1961, The pathogenesis of osteoporosis, Lancet i:1011–1014.Google Scholar
  16. 16.
    Smith, R. W., Jr. and Frame, B., 1965, Concurrent axial and appendicular osteoporosis: Its relation to calcium consumption, N. Engl. J. Med. 273:73–78.PubMedGoogle Scholar
  17. 17.
    Nordin, B. E. C., 1962, Calcium balance and calcium requirement in spinal osteoporosis, Am. J. Clin. Nutr. 10:384–390.PubMedGoogle Scholar
  18. 18.
    Heaney, R. P., Recker, R. R., and Saville, P. D., 1977, Calcium balance and calcium requirements in middle-aged women, Am. J. Clin. Nutr. 30:1603–1611.PubMedGoogle Scholar
  19. 19.
    Recker, R. R., Saville, P. D., and Heaney, R. P., 1977, Effect of estrogens and calcium carbonate on bone loss in postmenopausal women, Ann. Intern. Med. 87:649–655.PubMedGoogle Scholar
  20. 20.
    Horsman, A., Gallagher, J. C., Simpson, M., and Nordin, B. E. C., 1977, Prospective trial of oestrogen and calcium in postmenopausal women, Br. Med. J. 2:789–792.PubMedGoogle Scholar
  21. 21.
    Nordin, B. E. C., Horsman, A., Marshall, D. H., Simpson, M., and Waterhouse, G. M., 1979, Calcium requirements and calcium therapy, Clin. Orthop. 10:216–239.Google Scholar
  22. 22.
    Nordin, B. E. C., Horsman, A., Crilly, R. G., Marshall, D. H., and Simpson, M., 1980, Treatment of spinal osteoporosis in postmenopausal women, Br. Med. J. 280:4451–4454.Google Scholar
  23. 23.
    Barzel, U. S., 1970, The role of bone in acid base metabolism, in: Osteoporosis (U. S. Barzel, ed.), Grune and Stratton, New York, pp. 199–206.Google Scholar
  24. 24.
    Barzel, U. S. and Jowsey, J., 1969, The effects of chronic acid and alkali administration on bone turnover in adult rats, Clin. Sci. 36:517–524.PubMedGoogle Scholar
  25. 25.
    Barzel, U. S., 1975, Acid induced osteoporosis: An experimental model of human osteoporosis, in: Calcified Tissues 1975 (Nielsen, S. P. and Hjfbrting-Hansen, E., eds.) FADL’s FORLAG, Copenhagen, pp. 417–422.Google Scholar
  26. 26.
    Johnson, N. E., Alcantara, E. N., and Linkswiler, H. M., 1970, Effect of level of protein intake on urinary and fecal calcium and calcium retention of young adult males, J. Nutr. 100:1425–1430.PubMedGoogle Scholar
  27. 27.
    Anand, C. R. and Linkswiler, M. D., 1974, Effect of protein intake on calcium balance of young men given 500 mg calcium daily, J. Nutr. 104:695–700.PubMedGoogle Scholar
  28. 28.
    Walker, R. M. and Linkswiler, H. M., 1972, Calcium retention in the adult human male as affected by protein intake, J. Nutr. 102:1297–1302.PubMedGoogle Scholar
  29. 29.
    Margen, S., Chu, J. Y., Kaufman, N. A., and Calloway, O. H., 1974, Studies in calcium metabolism. I. The calciuretic effect of dietary protein, Am. J. Clin. Nutr. 27:584–589.PubMedGoogle Scholar
  30. 30.
    Chu, J. Y., Margen, S., and Costa, F. M., 1975, Studies in calcium metabolism. II. Effects of low calcium and variable protein intake on human calcium metabolism, Am. J. Clin. Nutr. 28:1028–1035.PubMedGoogle Scholar
  31. 31.
    Spencer, H., Kramer, L., and Osis, D., 1978, Effect of a high protein (meat) intake on calcium metabolism in man, Am. J. Clin. Nutr. 31:2167–2180.PubMedGoogle Scholar
  32. 32.
    Spencer, H., Kramer, L., Osis, D., and Norris, C., 1978, Effect of phosphorus on the absorption of calcium and on the calcium balance in man, J. Nutr. 108:447–457.PubMedGoogle Scholar
  33. 33.
    Heaney, R. P., 1981, Nutritional, hormonal, and mechanical factors in age-related bone loss, International Symposium on Osteoporosis, Jerusalem, Israel, May 31-June 4, 1981, in press.Google Scholar
  34. 34.
    Nordin, B. E. C., Horsman, A., Brook, R., and Williams, D. A., 1976, The relationship between oestrogen status and bone loss in postmenopausal women, Clin. Endocrinol. 5(Suppl.):S353–S361.Google Scholar
  35. 35.
    Cohn, S. H., Vaswani, A., Zanzi, I., and Ellis, K. J., 1976, Effect of aging on bone mass in adult women, Am. J. Physiol. 230:143–148.PubMedGoogle Scholar
  36. 36.
    Smith, D. M., Khairi, M. R. A., Norton, J., and Johnston, C. C., Jr., 1976, Age and activity effects on rate of bone mineral loss, J. Clin. Invest. 68:716–721.Google Scholar
  37. 37.
    Lindsay, R., Aitken, J. M., Anderson, J. B., Hart, D. N., MacDonald, E. B., and Clark, A. C., 1976, Long-term prevention of postmenopausal osteoporosis by estrogen, Lancet i:1038–1041.Google Scholar
  38. 38.
    Horsman, A., Gallagher, J. C., Simpson, M., and Nordin, B. E. C., 1977, Prospective trial of oestrogen and calcium in postmenopausal women, Br. Med. J. 2:789–792.PubMedGoogle Scholar
  39. 39.
    Lindsay, R., MacLean, A., Kraszewsky, A., Hart, D. M., Clark, A. C., and Garwood, J., 1978, Bone response to termination of oestrogen treatment, Lancet i:1325–1327.Google Scholar
  40. 40.
    Horsman, A., Nordin, B. E. C., and Crilly, R. G., 1979, Effect on bone of withdrawal of oestrogen therapy, Lancet ii:33.Google Scholar
  41. 41.
    Frumar, A. M., Meldrum, D. R., Geola, F., Shamonki, I. M., Tataryn, I. V., Deftos, L. J., and Judd, H. L., 1980, Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women, J. Clin. Endocrinol. Metabol. 50:70.Google Scholar
  42. 42.
    Caputo, C. B., Meadows, D., and Raisz, L. G., 1976, Failure of estrogens and androgens to inhibit bone resorption in tissue culture, Endocrinology 98:1065–1068.PubMedGoogle Scholar
  43. 43.
    van Paassen, H. C., Poortman, J., Borgart-Creutzburg, I. H. C., Thijsson, J. H., and Duursma, S. A., 1978, Oestrogen binding proteins in bone cell cytosol, Calcif. Tissue Res. 25:249–254.PubMedGoogle Scholar
  44. 44.
    Chen, T. L. and Feldman, D., 1978, Distinction between alpha-fetoprotein and intracellular estrogen receptors: Evidence against the presence of estradiol receptors in rat bone, Endocrinology 102:236–244.PubMedGoogle Scholar
  45. 45.
    Schweikert, H. U., Rulf, W., Niederle, N., Schaefer, H. E., and Kruck, E., 1979, Dihydrotestosterone formation in normal and osteoporotic human bone, in: Osteoporosis II (U. S. Barzel, ed.), Grune and Stratton, New York, p. 247.Google Scholar
  46. 46.
    Heaney, R. P., Recker, R. R., and Saville, P. D., 1978, Menopausal changes in calcium balance performance, J. Lab. Clin. Med. 92:953–963.PubMedGoogle Scholar
  47. 47.
    Gallagher, J. C., Riggs, B. L., Hamstra, A., and DeLuca, H. F., 1978, Effect of estrogen therapy on calcium absorption and vitamin D metabolism in postmenopausal osteoporosis, Clin. Res. 26:415a.Google Scholar
  48. 48.
    Spencer, H., Kramer, L., Gatza, C. A., and Lender, M., 1979, Calcium loss, calcium absorption, and calcium requirement in osteoporosis, in: Osteoporosis II (U. S. Barzel, ed.), Grune and Stratton, New York, pp. 65–89.Google Scholar
  49. 49.
    Dalen, N. and Lamke, B., 1976, Bone mineral losses in alcoholics, Acta Orthop. Scand. 197:353.Google Scholar
  50. 50.
    Baran, D. T., Teitelbaum, S. L., Bergfeld, M. A., Hamilton, J. B., Hahn, A. J., Hahn, T. J., and Avioli, L. V., 1980, Effect of alcohol ingestion on bone and mineral metabolism in rats, Am. J. Physiol. 238:E507-E510.PubMedGoogle Scholar
  51. 51.
    Dalen, N., Hallberg, D., and Lamke, B., 1975, Bone mass in obese subjects, Acta Med. Scand. 197:353.PubMedGoogle Scholar
  52. 52.
    Daniell, H. W., 1976, Osteoporosis of the slender smoker—Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity, Arch. Intern. Med. 136:298–304.PubMedGoogle Scholar
  53. 53.
    Lindquist, O. and Bengtsson, C., 1979, The effect of smoking on menopausal age, Maturitas 1:171–173.PubMedGoogle Scholar
  54. 54.
    Lindquist, O., Bengtsson, C., Hansson, T., and Roos, B., 1979, Age at menopause and its relation to osteoporosis, Maturitas 1:175–181.PubMedGoogle Scholar
  55. 55.
    Heaney, R. P. and Recker, R. R., 1982, Effects of nitrogen, phosphorus, and caffeine on calcium balance in women, J. Lab. Clin. Med. 99:46–55.PubMedGoogle Scholar
  56. 56.
    Minaire, P., Meunier, P., Edouard, C., Berhard, J., and Courpron, P., 1975, Osteomorphometric and biochemical data on osteoporosis resulting from immobilization, Rev. Rheum. 42:479–488.Google Scholar
  57. 57.
    Uhthoff, H. K. and Jaworski, Z. F. G., 1978, Bone loss in response to long-term immobilisation, J. Bone Joint Surg. 60B:420–429.Google Scholar
  58. 58.
    Avioli, L. V., 1978, What to do with “postmenopausal osteoporosis?” Am. J. Med. 65:881–884.PubMedGoogle Scholar
  59. 59.
    Habener, J. F. and Mahaffey, J. E., 1978, Osteomalacia and disorders of vitamin D metabolism, Ann. Rev. Med. 29:327–342.PubMedGoogle Scholar
  60. 60.
    Mundy, G. R., Cove, D. H., and Fisken, R., 1980, Primary hyperparathyroidism: Changes in the pattern of clinical presentation, Lancet i: 1317.Google Scholar
  61. 61.
    Heath, H., III, Hodgson, S. F., and Kennedy, M. A., 1980, Primary hyperparathyroidism: Incidence, morbidity, and potential economic impact in a community, N. Engl. J. Med. 302:189–193.PubMedGoogle Scholar
  62. 62.
    Aloia, J. F., Petrak, Z., Ellis, K., and Cohn, S. H., 1976, Body composition and skeletal metabolism following pituitary irradiation in acromegaly, Am. J. Med. 61:59–63.PubMedGoogle Scholar
  63. 63.
    Avioli, L., Jost, R. G., Cryer, P., Slatopolsky, E., Teitelbaum, S. T., Coxe, W., and Whyte, M., 1980, Vertebral compression fractures with accelerated bone turnover in a patient with Cushing’s disease. Am. J. Med. 68:932.Google Scholar
  64. 64.
    Mundy, G. R., Shapiro, J. L., Bandelin, J. G., Canalis, G. M., and Raisz, L. G., 1976, Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 58:529–534.PubMedGoogle Scholar
  65. 65.
    Condon, J. R., Dent, C. E., Nassim, J. R., Hilb, A., and Stainthorpe, E. M., 1978, Possible prevention and treatment of steroid-induced osteoporosis, Postgrad. Med. J. 54:249–253.PubMedGoogle Scholar
  66. 66.
    Hahn, T. J., Halstead, L. R., Teitelbaum, S. L., and Hahn, B. H., Altered mineral metabolism in glucocorticoid-induced osteopenia: Effect of 25-hydroxyvitamin D administration, J. Clin. Invest. 64:655–665.Google Scholar
  67. 67.
    Avioli, L. V., 1975, Heparin-induced osteopenia: An appraisal, Adv. Exp. Med. Biol. 52:375.PubMedGoogle Scholar
  68. 68.
    Wise, P. H. and Hall, A. J., 1980, Heparin-induced osteopenia in pregnancy, Br. Med. J. 281:110–111.PubMedGoogle Scholar
  69. 69.
    Long, R. G., 1980, Hepatic osteodystrophy: Outlook good but some problems unsolved, Gastroenterology 78:644–647.PubMedGoogle Scholar
  70. 70.
    Aloia, J. F., Cohn, S. H., Ostuni, J. A., Cane, R., and Ellis, K., 1978, Prevention of involutional bone loss by exercise, Ann. Intern. Med. 89:356–358.PubMedGoogle Scholar
  71. 71.
    Huddleston, A. L., Rockwell, D., Kulund, D. N., and Harrison, R. B., 1980, Bone mass in lifetime tennis athletes, JAMA 244:1107–1109.PubMedGoogle Scholar
  72. 72.
    Aloia, J. F., Cohn, S. H., Babu, T., Abesamis, C., Kalici, N., and Ellis, K., 1978, Skeletal mass and body composition in marathon runners, Metabolism 27:1793–1796.PubMedGoogle Scholar
  73. 73.
    Smith, D. M., Nance, W. E., Kang, K. W., Christian, J. C., and Johnston, C. C., Jr., 1973, Genetic factors in determining bone mass, J. Clin. Invest. 52:2800–2808.PubMedGoogle Scholar
  74. 74.
    Cohn, S. H., Abesamis, C., Yasumura, S., Aloia, J. F., Zanzi, I., and Ellis, K. J., 1977, Comparative skeletal mass and radial bone mineral content in black and white women, Metabolism 26:171–178.PubMedGoogle Scholar
  75. 75.
    Lindsay, R., Hart, D. M., Purdie, D., Ferguson, M. M., Clark, A. C., and Kraszewsky, A., 1978, Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women, Clin. Sci. Mol. Med. 54:193–195.PubMedGoogle Scholar
  76. 76.
    Lindsay, R., Hart, D. M., Maclean, A., Garwood, J., Clark, A. C., and Kraszewski, A., 1979, Bone loss during oestriol therapy in postmenopausal women, Maturitas 1:279–285.PubMedGoogle Scholar
  77. 77.
    Dequeker, J., De Muylder, E., and Ferin, J., 1977, The effect of long-term lynes-trenol treatment on bone mass in cycling women, Contraception 15:717–723.PubMedGoogle Scholar
  78. 78.
    Hutchinson, I. A., Polansky, S. M., and Feinstein, A. R., 1979, Postmenopausal oestrogens protect against fractures of hip and distal radius: A case-control study, Lancet ii:705.Google Scholar
  79. 79.
    Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., and Beckman, E. M., 1979, Estrogen replacement therapy. I: A 10-year prospective study in the relationship to osteoporosis, Obstet. Gynecol. 53:277–281.PubMedGoogle Scholar
  80. 80.
    Chestnut, C. H., III, Nelp, W. B., Baylink, D. J., and Denney, J. D., 1977, Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass, Metabolism 26:267’-277’.Google Scholar
  81. 81.
    Lindsay, R., Hart, D. M., and Kraszewski, A., 1980, Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis, Br. Med. J. 280:1207–1209.PubMedGoogle Scholar
  82. 82.
    Bloch-Michel, H., Milhaud, G., and Cortris, G., 1970, Prolonged treatment of osteoporosis with thyrocalcitonin. Report of 7 cases, Rev. Rheum. 37:629.Google Scholar
  83. 83.
    Aloia, J. F., Zanzi, I., Ellis, K., and Cohn, S. H., 1977, Combination therapy for osteoporosis, Metabolism 26:787–792.PubMedGoogle Scholar
  84. 84.
    Jowsey, J., Riggs, B. L., Kelly, P. H., and Hoffman, D. L., 1978, Calcium and salmon calcitonin in treatment of osteoporosis, J. Clin. Endocrinol. Metab. 47:633–639.PubMedGoogle Scholar
  85. 85.
    Wallach, S., Cohn, S. H., Atkins, H. L., Ellis, K. J., Kohberger, R, Aloia, J. F, and Zanzi, I., 1977, Effect of salmon calcitonin on skeletal mass in osteoporosis, Curr. Ther. Res. 22:556–572.Google Scholar
  86. 86.
    Rasmussen, H., Bordier, P., Marie, P., Auquier, L., Eisinger, J. B., Kuntz, O., Caulin, F., Argemi, B., Gueris, S., and Julien, A., 1980, Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis, Metab. Bone Dis. Rel. Res. 2:107–111.Google Scholar
  87. 87.
    Reeve, J., Hesp, R., Williams, D., Hulme, P., Klenerman, L., Zanelli, J. M., Darby, A. J., Tregear, G. W., and Parsons, J. A., 1976, Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis, Lancet i: 1035–1038.Google Scholar
  88. 88.
    Riggs, B. L., Jowsey, J., Kelly, P. J., Hoffman, D. L., and Arnaud, G. D., 1976, Effects of oral therapy with calcium and vitamin D in primary osteoporosis, J. Clin. Endocrinol. Metab. 42:1139–1144.PubMedGoogle Scholar
  89. 89.
    Lawoyin, S., Zerwekh, J. E., Glass, K., and Pak, C. Y. C., 1980, Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis, J. Clin. Endocrinol. Metab. 60:595–596.Google Scholar
  90. 90.
    Cohen, H. N., Farrah, D., Fogelman, L, Goll, C. C., Beastall, G. H., Mcintosh, W. B., Fletcher, M., and Boyle, I. T., 1980, A low dose regime of 1-alpha-hydroxyvitamin D3 in the management of senile osteoporosis: A pilot study, Clin. Endocrinol. 12:537–542.Google Scholar
  91. 91.
    Hoikka, V., Alhava, E. M., Aro, A., Karjalai, P., and Rehnberg, V., 1980, Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium, Acta Med. Scand. 207:221–224.PubMedGoogle Scholar
  92. 92.
    Wandless, I., Jarvis, S., Evans, J. G., Aird, E. G. A., and Stevens, J., 1980, Vitamin D3 in osteoporosis, Br. Med. J. 280:1320.PubMedGoogle Scholar
  93. 93.
    Heaney, R. P. and Saville, P. D., 1976, Etidronate disodium in post-menopausal osteoporosis, Clin. Pharmacol. Ther. 20:593–604.PubMedGoogle Scholar
  94. 94.
    Jowsey, J., Riggs, B. L., Kelly, P. J., and Hoffman, D. L., 1972, Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis, Am. J. Med. 53:43–49.PubMedGoogle Scholar
  95. 95.
    Compston, J. E., Chadha, S., and Merrett, A. L., 1980, Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D, Br. Med. J. 281:910–911.PubMedGoogle Scholar
  96. 96.
    Riggs, B. L., Hodgson, S. F., Hoffman, D. L., Kelly, P. J., Johnson, K. A., and Taves, D., 1980, Treatment of primary osteoporosis with fluoride and calcium, JAMA 243:446–449.PubMedGoogle Scholar
  97. 97.
    Reutter, F. W. and Olaf, A. J., 1978, Bone biopsy findings and clinical observations in long-term treatment of osteoporosis with sodium fluoride and vitamin D3, in: Fluoride and Bone (B. Courvoisier, A. Donath, and C. A. Baud, eds.) Hans Huker, Berne.Google Scholar
  98. 98.
    Dequeker, J., 1976, Quantitative radiology: Radiogrammetry of cortical bone, Br. J. Radiol. 49:912–920.PubMedGoogle Scholar
  99. 99.
    Dunn, W. L., Wahner, H. W., and Riggs, B. L., 1980, Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry, Radiology 136:485–487.PubMedGoogle Scholar
  100. 100.
    Jensen, P. S., Orphanoudakis, S. C., Rauschkolb, E. N., Baron, R., Lang, R., and Rassmusen, H., Assessment of bone mass in the radius by computed tomography, Am. J. Roentgenol. 134:285–292.Google Scholar
  101. 101.
    Boyce, B. F., Dourpron, P., and Meunier, P. J., 1978, Amount of bone in osteoporosis and physiological senile osteopenia. Comparison of two histomorphometric parameters, Metab. Bone Dis. Rel. Res. 1:35–38.Google Scholar
  102. 102.
    Lauffenburger, T., Olah, A. J., Dambacher, M. A., Guncaga, J., Leutner, C., and Haas, H. G., 1977, Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget’s disease, Metabolism 26:589–606.PubMedGoogle Scholar
  103. 103.
    Manzke, E., Chestnut, C. H., III, Wergedal, J. E., Baylink, D. J., and Nelp, W. B., 1975, Relationship between local and total bone mass in osteoporosis, Metabolism 24:605–615.PubMedGoogle Scholar
  104. 104.
    Cohn, S. H., Vaswani, A., Zanzi, I., Aloia, J. F., Roginsky, M. S., and Ellis, K. J., 1976, Changes in body chemical composition with age measured by total-body neutron activation, Metabolism 25:85–96.PubMedGoogle Scholar
  105. 105.
    Harrison, J. E., McNeill, K. G., Hitchman, A. J., and Britt, B. A., 1979, Bone mineral measurements of the central skeleton by in vivo neutron activation analysis for routine investigation of osteopenia, Invest. Radiol. 14:27–34.PubMedGoogle Scholar
  106. 106.
    Aloia, J. F., Cohn, S. H., Ross, P., Vaswani, A., Abesamis, C., Ellis, K., and Zanzi, I., 1978, Skeletal mass in post-menopausal women, Am. J. Physiol. 235:E82-E87.PubMedGoogle Scholar
  107. 107.
    Riggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R., and O’Fallon, W. M., 1982, Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis, N. Engl. J. Med. 306:446–450.PubMedGoogle Scholar
  108. 108.
    Habener, J. F. and Mahaffey, J. E., 1978, Osteomalacia and disorders of vitamin-D metabolism, Ann. Rev. Med. 29:327.PubMedGoogle Scholar
  109. 109.
    Dent, C. E. and Stamp, T. C. B., 1977, Vitamin D., rickets, and osteomalacia, in: Metabolic Bone Disease (L. V. Avioli and S. M. Krane, eds.), Academic Press, New York.Google Scholar
  110. 110.
    Frame, B. and Parfitt, A. M., 1978, Osteomalacia: Current concepts, Ann. Intern. Med. 89:966–982.PubMedGoogle Scholar
  111. 111.
    Jowsey, J., 1977, Metabolic Diseases of Bone, W. B. Saunders, Philadelphia.Google Scholar
  112. 112.
    Mallette, L. E., Patten, B. M., and Engel, W. K., 1975, Neuromuscular disease in secondary hyperparathyroidism, Ann. Intern. Med. 82:474–483.PubMedGoogle Scholar
  113. 113.
    Schott, G. D. and Wills, M. R., 1976, Muscle weakness in osteomalacia, Lancet i:626–629.Google Scholar
  114. 114.
    Sokoloff, L., 1978, Occult osteomalacia in American (USA) patients with fracture of the hip, Am. J. Surg. Pathol. 2:21–30.PubMedGoogle Scholar
  115. 115.
    Adams, J. S., Clemen, T. L., Parrish, J. A., and Holick, M. F., 1982, Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects, N. Engl. J. Med. 306:722–725.PubMedGoogle Scholar
  116. 116.
    Hahn, T. J. and Avioli, L. V., 1975, Anticonvulsant osteomalacia, Arch. Intern. Med. 135:997–1000.Google Scholar
  117. 117.
    Thompson, W. G. and Thompson, G. R., 1969, Effect of cholestyramine on the absorption of vitamin D3 and calcium, Gut 10:717–722.PubMedGoogle Scholar
  118. 118.
    Kantrowitz, F. G., Byrne, M. H., and Krane, S. M., 1975, Clinical and biochemical effects of the diphosphonate in Paget’s disease of bone, Arthritis Rheum. 18:407.Google Scholar
  119. 119.
    Long, R. G., Skinner, R. K., Wills, M. R., and Sherlock, S., 1976, Serum 25-hydroxyvitamin D in untreated parenchymal and cholestatic liver disease, Lancet ii:650–652.Google Scholar
  120. 120.
    Marx, S. J., Spiegel, A. M., Brown, E. M., Gardner, D. G., Downs, R. W., Attie, M., Hamstra, A. J., and DeLuca, H. F., 1978, Familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D, J. Clin. Endocrinol. Metab. 47:1303–1310.PubMedGoogle Scholar
  121. 121.
    Rasmussen, H. and Anast, C., 1978, Familial hypophosphatemic (vitamin D-resistant) rickets and vitamin D-dependent rickets, in: Metabolic Basis of Inherited Disease, 4th ed. (J. B. Stanbury and J. B. Wyngaarden, eds.), McGraw-Hill, New York, p. 1537.Google Scholar
  122. 122.
    Drezner, M. K. and Feinglos, M. N., 1977, Osteomalacia due to l-alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone, J. Clin. Invest. 60:1046.PubMedGoogle Scholar
  123. 123.
    Singer, F. R., 1977, Paget’s Disease of Bone, Plenum Press, New York.Google Scholar
  124. 124.
    Rebel, A., Basle, M., Poupcard, A., Kouyoumdkoam, S., Filmon, R., and Lepatelour, A., 1980, Viral antigens in osteoclasts from Paget’s disease of bone, Lancet ii:344–346.Google Scholar
  125. 125.
    Mills, B. G. and Singer, F. R., 1976, Nuclear inclusions in Paget’s disease of bone, Science 194:201–202.PubMedGoogle Scholar
  126. 126.
    Miller, S. W., Castronovo, F. P., Prendergrass, H. P., and Potsaid, M. S., 1974, Technetium 99M labeled diphosphonate bone scanning in Paget’s disease, Am. J. Roentgenol. 121:177–183.Google Scholar
  127. 127.
    Ross, F. G. M., Middlemiss, J. H., and Fitton, J. M., 1973, Paget’s sarcoma in bone—a radiological study, in: BoneCertain Aspects of Neoplasia (C. H. G. Price and F. G. M. Ross, eds.), Buttersworths, London.Google Scholar
  128. 128.
    Franck, W. A., Bress, N. M., Singer, F. R., and Krane, S. M., 1974, Rheumatic manifestations of Paget’s disease of bone, Am. J. Med. 56:592–603.PubMedGoogle Scholar
  129. 129.
    DeRose, J., Singer, F. R., Avramides, A., Flores, A., Dziadiw, R., Baker, R. K., and Wallach, S., 1974, Response of Paget’s disease to porcine and salmon calcitonins, Am. J. Med. 56:858–866.PubMedGoogle Scholar
  130. 130.
    Avramides, A., Flores, A., DeRose, J., and Wallach, S., 1976, Paget’s disease of the bone: Observations after cessation of long-term synthetic salmon calcitonin treatment, J. Clin. Endocrinol. Metab. 42:459–463.PubMedGoogle Scholar
  131. 131.
    Kantrowitz, F. G., Byrne, M. H., and Krane, S. M., 1975, Clinical and metabolic effect of diphosphonate EHDP in Paget’s disease of bone, Clin. Res. 23:445A.Google Scholar
  132. 132.
    Canfield, R., Rosner, W., Skinner, J., McWhorter, J., Resnick, L., Feldman, F., Kammerman, S., Ryan, K., Kunigonis, M., and Bohne, W., 1977, Diphosphonate therapy of Paget’s disease of bone, J. Clin. Endocrinol. Metab. 44:96–106.PubMedGoogle Scholar
  133. 133.
    Khairi, M. R. A., Altman, R. D., DeRose, G. P., Zimmerman, J., Schenk, R. K., and Johnston, C. C., Jr., 1977, Sodium etidronate in the treatment of Paget’s disease of bone: A study of long term results, Ann. Intern. Med. 87:656–663.PubMedGoogle Scholar
  134. 134.
    Johnston, C. C., Jr., Khairi, M. R. A., and Meunier, P. J., 1980, Use of etidronate (EHDP) in Paget’s disease of bone, Arthritis Rheum. 23:1172–1176.PubMedGoogle Scholar
  135. 135.
    Siris, E. S., Canfield, R. E., Jacobs, T. P., and Baquiran, D. C., 1980, Long-term therapy of Paget’s disease of bone with EHDP, Arthritis Rheum. 23:1177–1184.PubMedGoogle Scholar
  136. 136.
    Delmas, P. D., Chapuy, M. C., Vignon, E., Charhon, S., Briancon, D., Alexandre, C., Eduard, C., and Meunier, P. J., 1982, Long term effects of dichloro-methylene diphosphonate in Paget’s disease of bone, J. Clin. Endocrinol. Metab. 54:837–844.PubMedGoogle Scholar
  137. 137.
    Evans, R. A., 1977, A cheap oral therapy for Paget’s disease of bone, Aust. N.Z. J. Med. 7:259–261.PubMedGoogle Scholar
  138. 138.
    Russell, A. S., Chalmers, I. M., Percy, J. S., and Lentle, B. C., 1979, Long term effectiveness of low dose mithramycin for Paget’s disease of bone, Arthritis Rheum. 22:215–218.PubMedGoogle Scholar
  139. 139.
    Tzankoff, S. P. and Norris, A. H., 1977, Effect of muscle mass decrease in age-related BMR changes, J. Appl. Physiol. 43:1001–1006.PubMedGoogle Scholar
  140. 140.
    Denckla, W. D., 1974, Role of the pituitary and thyroid glands on the decline of minimal O2 consumption with age, J. Clin. Invest. 53:572–581.PubMedGoogle Scholar
  141. 141.
    Ingbar, S., 1978, The influence of aging on human thyroid economy, in: Geriatric Endocrinology (R. B. Greenblatt, eds.), Raven Press, New York.Google Scholar
  142. 142.
    Braverman, L., Dawber, N., and Ingbar, S., 1966, Observations concerning the binding of thyroid hormone in the sera of normal subjects of varying ages, J. Clin. Invest. 45:1273–1279.PubMedGoogle Scholar
  143. 143.
    Hesch, R. D., Gatz, J., and Pope, J., 1976, Total and free triiodothyronine and thyroid-binding globulin concentration in elderly human persons, Eur. J. Clin. Invest. 6:139–145.PubMedGoogle Scholar
  144. 144.
    Davis, P. and Davis, F., 1974, Hyperthyroidism in patients over the age of 60 years, Medicine, 53:161–181.PubMedGoogle Scholar
  145. 145.
    Hermann, J., Rusche, H. J., Kroll, H. J., Hilger, P., and Kruskemper, H. L., 1974, Free triiodothyronine (T3) and thyroxine (T4) serum levels in old age, Horm. Metab. Res. 6:239–240.Google Scholar
  146. 146.
    Wenzel, K. W. and Horn, W. R., June 1975, Triiodothyronine (T3) and thyroxine (T4) kinetics in aged men. Program, 7th International Thyroid Conference, Boston, Excerpta Medica, ICS #361, Abstract No. 154.Google Scholar
  147. 147.
    Chopra, I. J. and Smith, S. R., 1975, Circulating thyroid hormones and thyrotropin in adult patients with protein-caloric malnutrition, J. Clin. Endocrinol. Metab. 40:221–227.PubMedGoogle Scholar
  148. 148.
    Mashang, T., Jr., Parks, J. S., Baker, L., Vaidya, V., Utiger, R. D., Bongiovanni, A. M., and Snyder, P. J., 1975, Low serum triiodothyronine in patients with anorexia nervosa, J. Clin. Endocrinol. Metab. 40:470–473.Google Scholar
  149. 149.
    Chopra, I. J., Chopra, U., Smith, S. R., Reza, M., and Solomon, D., 1975, Reciprocal changes in serum concentrations of 3,3’5’-triiodothyronine (reverse T3) and 3,3’,5-triiodothyronine (T3) in systemic illnesses, J. Clin. Endocrinol. Metab. 41:1043–1049.PubMedGoogle Scholar
  150. 150.
    Bermudez, F., Surks, M. I., and Oppenheimer, J. H., 1975, High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease, J. Clin. Endocrinol. Metab. 41:27–40.PubMedGoogle Scholar
  151. 151.
    Burrows, A. W., Cooper, E., Shakespear, R. A., Aickin, C. M., Hesch, R. D., and Burke, C. W., 1977, Low serum T3 levels in the elderly sick: Protein binding, thyroid and pituitary responsiveness and reverse T3 concentrations, Clin. Endocrinol. 7:289–292.Google Scholar
  152. 152.
    Vagenakis, A. G., Burger, A., Portnay, G. I., Rudolph, M., O’Brien, J. T., Azizi, F., Arky, R. A., Nicod, P., Ingbar, S. H., and Braverman, L. E., 1975, Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting, J. Clin. Endocrinol. Metab. 41:191–194.PubMedGoogle Scholar
  153. 153.
    Balsam, A. and Ingbar, S. H., 1978, The influence of fasting, diabetes, and several pharmacological agents in the pathways of thyroxine metabolism in rat liver, J. Clin. Invest. 63:415–424.Google Scholar
  154. 154.
    Snyder, P. and Utiger, R., 1972, Response to TRH in normal man. J. Clin. Endocrinol. Metab. 34:380–385.PubMedGoogle Scholar
  155. 155.
    Azizi, F., Vagenakis, G. I., Portnay, B., Rapoport, B., Ingbar, S. H., and Braverman, L. E., 1975, Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, triiodothyronine and thyrotropin concentrations, N. Engl. J. Med. 292:273–276.PubMedGoogle Scholar
  156. 156.
    Cuttelod, S., Lemarchand-Beraud, T., Magnenat, P., Perret, C., Poli, S., and Venotti, A., 1974, Effect of age and role of kidneys and liver on thyrotropin turnover in man, Metabolism 23:101–113.PubMedGoogle Scholar
  157. 157.
    Lemarchand-Beraud, T. H. and Vanotti, A., 1969, Relationships between blood thyrotropin levels, protein bound iodine and free thyroxine concentration in man under normal physiological conditions, Acta Endocrinol. 60:315–317.PubMedGoogle Scholar
  158. 158.
    Ohara, H., Kobayaski, T., Shiraishi, M., and Wada, T., 1974, Thyroid function of the aged as viewed from the pituitary-thyroid system. Endocrinol. Jpn. 21:377–381.PubMedGoogle Scholar
  159. 159.
    Sawin, C. T., Chopra, D., Azizi, F., Mannix, J. E., and Bacharach, P., 1979, The aging thyroid: Increased prevalence of elevated serum thyrotropin levels in the elderly, J. Am. Med. Soc. 242:247–250.Google Scholar
  160. 160.
    Snyder, P. J. and Utiger, R. D., 1972, Thyrotropin response to thyrotropin releasing hormone in normal females over forty, J. Clin. Endocrinol. Metab. 34:1096–1101.PubMedGoogle Scholar
  161. 160a.
    Ordene, K. W., Pan, C., Barzel, U. S., and Surks, M. F., 1982, Abnormal TSH regulation in aging patients, Clin. Res. 30:553A (Abstract).Google Scholar
  162. 161.
    Wenzel, K. W., Meinhold, H., Herpich, M., Adlkofer, F., and Schleusener, H., 1974, TRH-Stimulationstest mit alters-und geschlechsabhangigem TSH-Antieg bein Normalpersonen, Klin. Wochenschr. 52:721–724.Google Scholar
  163. 162.
    Campbell, A. J., Reinken, J., and Allan, B. C., 1981, Thyroid disease in the elderly community, Age Ageing 10:47–52.PubMedGoogle Scholar
  164. 163.
    Gambert, S. R., Garthwaite, T. L., Pontzer, C. H., and Hagen, T. C., 1980, Age-related changes in central nervous system beta-endorphin and ACTH, Neuroen-docrinology 31:252–255.Google Scholar
  165. 164.
    Gambert, S. R., 1981, Interaction of age and thyroid hormone status on beta-endorphin content in rat corpus striatum and hypothalamus, Neuroendocrinology 32:114–117.PubMedGoogle Scholar
  166. 165.
    Lahey, F. H., 1931, Non-activated (apathetic) type of hyperthyroidism, N. Engl. J. Med. 204:747–748.Google Scholar
  167. 166.
    Gambert, S. R., Ingbar, S. H., and Hagen, T. C., 1980, Interaction of age and thyroid hormone status on Na+-K+ ATPase in rat renal cortex and liver, Endocrinology 108:27–30.Google Scholar
  168. 167.
    Jeffreys, P., 1972, The prevalence of thyroid disease in patients admitted to a geriatric department, Age Ageing 1:33–37.Google Scholar
  169. 168.
    Bahemuka, M. and Hodkinson, H., 1957, Screening for hypothyroidism in elderly patients, Br. Med. J. 2:601–605.Google Scholar
  170. 169.
    Ahconheim, J. and Libow, L., 1981, High occurrence rate of hypothyroidism in a frail elderly population. Proceedings of the 34th Annual Meeting of the Gerontological Society of America, Toronto, Canada, Abstract No. 162.Google Scholar
  171. 170.
    Ingbar, S. H. and Braverman, L. E., 1975, Active form of the thyroid hormone, Ann. Rev. Med. 26:443–447.PubMedGoogle Scholar
  172. 170a.
    Rosenbaum, R. L. and Barzel, U. S., 1981, Clinical hyperthyroidism in the elderly, J. Am. Geriatr. Soc. 29:221–223.PubMedGoogle Scholar
  173. 171.
    Kaplan, M. M., Larsen, P. R., Crantz, F. R., Dzau, V. J., and Rossing, T. H., 1982, Prevalence of abnormal thyroid function test results in patients with acute medical illnesses, Am. J. Med. 72:9–16.PubMedGoogle Scholar
  174. 172.
    Rosenbaum, R. L. and Barzel, U. S., 1982, Levothyroxine replacement dose for primary hypothyroidism decreases with age, Ann. Int. Med. 96:53–55.PubMedGoogle Scholar
  175. 173.
    Davis, E. B., Lamantia, R. S., Sapulding, S. W., and Davis, P. J., 1980, Conventional therapy overtreats elderly hypothyroid patients. Proceedings of the 62nd Annual Meeting of the Endocrine Society, Annaheim, California, Abstract No. 33.Google Scholar
  176. 174.
    Gregerman, R. I., Gaffney, G. W., and Shock, N. W., 1962, Thyroxine turnover in euthyroid man with special reference to changes with age, J. Clin. Invest. 41:2065–2074.PubMedGoogle Scholar
  177. 175.
    Murad, F. and Haynes, R. C., Jr., 1980, Androgens and anabolic steroids, in: The Pharmacological Basis of Therapeutics (A. Goodman Gilman, L. S. Goodman, and A. Gilman, eds.), MacMillan Publishing Co., New York, p. 1448.Google Scholar
  178. 176.
    Masters, W. H. and Johnson, V. E., 1966, Human Sexual Response, Little, Brown and Co., Boston, pp. 248–270.Google Scholar
  179. 177.
    Kinsey, A. C., Pomeroy, W. B., and Martin, C. E., 1948, Sexual Behavior in the Human Male, W. B. Saunders, Philadelphia.Google Scholar
  180. 178.
    Martin, C. E., 1977, Sexual activity in the aging male, in: Handbook of Sexology (J. Money and H. Mousafh, eds.), Elsevier, Amsterdam, pp. 813–824.Google Scholar
  181. 179.
    Harman, S. M., 1978, Clinical aspects of aging of the male reproductive system, in: The Aging Reproductive System, Aging, Volume 4 (E. L. Schneider, ed.), Raven Press, New York, pp. 29–58.Google Scholar
  182. 180.
    Karacan, I., Williams, R. L., Thronby, J. I., and Salis, P. J., 1975, Sleep related penile tumescence as a function of age, Am. J. Psychiatry, 132:932–937.PubMedGoogle Scholar
  183. 181.
    Johnson, J., 1975, Impotence, Br. J. Psychiatry 9:206–211.Google Scholar
  184. 182.
    Tsitouras, P. D., Martin, C. E., and Harman, S. M., 1982, Relationship of serum testosterone to sexual activity in healthy elderly men, J. Gerontol. 37(3):288–293.PubMedGoogle Scholar
  185. 183.
    Gregerman, R. I. and Bierman, E. L., 1981, Aging and hormones, in: Textbook of Endocrinology (R. H. Williams, ed.), W. B. Saunders, Philadelphia, pp. 1192–1212.Google Scholar
  186. 184.
    Bardin, C. W. and Paulsen, C. A., 1981, The testes, in: Textbook of Endocrinology (R. H. Williams, ed.), W. B. Saunders, Philadelphia, pp. 293–354.Google Scholar
  187. 185.
    Eik-Nes, K. B., 1975, Biosynthesis and secretion of testicular steroids, in: Handbook of Physiology, Section 7: Endocrinology, Volume V: Male reproductive system (D. W. Hamilton and R. O. Greep, eds.), Williams and Wilkins, Baltimore, pp. 95–116.Google Scholar
  188. 186.
    Kastin, A. J. and Schally, A. V., 1972, Release of LH and FSH after administration of synthetic LHRH, J. Clin. Endocrinol. Metab. 34:753–757.PubMedGoogle Scholar
  189. 187.
    Reichlin, S., 1981, Neuroendocrinology, in: Textbook of Endocrinology (R. H. Williams, ed.), W. B. Saunders, Philadelphia, pp. 588–644.Google Scholar
  190. 188.
    Vermeulen, A., Rubens, R., and Verdonck, L., 1972, Testosterone secretion and metabolism in male senescence, J. Clin. Endocrinol. Metab. 34:730–735.PubMedGoogle Scholar
  191. 189.
    Stearns, E. L., MacDonald, J. A., Kaufman, B. J., Lucman, T. S., Winter, J. S., and Faiman, C., 1974, Declining testicular function with age, hormonal and clinical correlates, Am. J. Med. 57(5):761–766.PubMedGoogle Scholar
  192. 190.
    Baker, H. W. G., Brenner, W. J., Burger, H. G., DeKretser, D. M., Dulmans, A., Eddie, L. W., Hudson, B., Keogh, E. J., Lee, V. W. K., and Rennie, G. C., 1976, Testicular control of follicle stimulating hormone secretion, Recent Prog. Horm. Res. 32:429–476.PubMedGoogle Scholar
  193. 191.
    Pirke, K. M. and Doerr, P., 1973, Age related changes and interrelationships between plasma testosterone, estradiol, and testosterone binding globulin in normal adult males, Acta Endocrinol. 74:729–800.Google Scholar
  194. 192.
    Horton, R., Hsieh, P., Barberia, J., Pages, L., and Cosgrove, M., 1975, Altered blood androgens in elderly men with prostate hyperplasia, J. Clin. Endocrinol. Metab. 41(4):793–796.PubMedGoogle Scholar
  195. 193.
    Vermeulen, A. and Verdonck, L., 1972, Some studies on the biological significance of free testosterone, J. Steroid. Biochem. 3:421–426.PubMedGoogle Scholar
  196. 194.
    Kley, H. K., Nieschlag, E., Bidlingmaier, F., and Krüskemper, H. L., 1974, Possible age-dependent influence of estrogens on the binding of testosterone in plasma of adult men, Horm. Metab. Res. 6:213–216.PubMedGoogle Scholar
  197. 195.
    Pirke, K. M. and Doerr, P., 1975, Age related changes in free plasma testosterone, dihydrotestosterone, and estradiol, Acta. Endocrinol. 80 (1):171–178.PubMedGoogle Scholar
  198. 196.
    Rubens, R. M., Dhout, M., and Vermeulen, A., 1974, Further studies on Leydig cell function in old age, J. Clin. Endocrinol. Metab. 39:40–45.PubMedGoogle Scholar
  199. 197.
    Hemsell, D. L., Grodin, J. M., Brenner, P. F., Siiteri, P. K., and McDonald, P. C., 1974, Plasma precursors of estrogen. II: Correlation of the extent of conversion of plasma androstenedione to estrone with age, J. Clin. Endocrinol. Metab. 38:476–479.PubMedGoogle Scholar
  200. 198.
    Greenblatt, R. B., Oettinger, M., and Bohler, C. S. S., 1976, Estrogen-androgen levels in aging men and women, therapeutic considerations, J. Am. Geriatr. Soc. 24:173–178.PubMedGoogle Scholar
  201. 199.
    Longcope, C., 1973, The effect of human chorionic gonadotrophin on plasma steroid levels in young and old men, Steroids 21:583–592.PubMedGoogle Scholar
  202. 200.
    Mazzi, C., Riva, L. R., and Bernasconi, D., 1974, Gonadotrophins and plasma testosterone in senescence, in: The Endocrine Function of the Human Testis, Volume 2 (V. H. T. James, M. Serio, and L. Martin, eds.), Academic Press, New York, pp. 51–62.Google Scholar
  203. 201.
    Tillenger, L. G., Birke, G., Franksson, C., and Plantin, L. O., 1955, The steroid production of the testicles and the relation to the number and morphology of Ley-dig cells, Acta Endocrinol. 19:340–348.Google Scholar
  204. 202.
    Kaler, L. W. and Neaves, W. B., 1978, Attrition of the human Leydig cell population with advancing age, Anat. Rec. 192(4):513–518.PubMedGoogle Scholar
  205. 203.
    Harman, S. M. and Tsitouras, P. D., 1980, Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin, J. Clin. Endocrinol. Metab. 51:35–40.PubMedGoogle Scholar
  206. 204.
    Harman, S. M. and Tsitouras, P. D., 1982, Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone, J. Clin. Endocrinol. Metab. 54:547–551.PubMedGoogle Scholar
  207. 205.
    Brenner, W. J. and Prinz, P. N., 1981, The diurnal rhythm in testosterone levels is lost with aging in normal men, 63rd Annual Meeting of the Endocrine Society, Abstract No. 480, Cincinnati, Ohio, Endocrine Society.Google Scholar
  208. 206.
    Sparrow, D., Bosse, R., and Rowe, J. W., 1980, The influence of age, alcohol consumption and body build on gonadal function in men, J. Clin. Endocrinol. Metab. 51:508–512.PubMedGoogle Scholar
  209. 207.
    Pazzagli, M., Forti, G., Capellini, A., and Serio, M., 1975, Radioimmunoassay of plasma dihydrotestosterone in normal and hypogonadal men, Clin. Endocrinol. 4:513–520.Google Scholar
  210. 208.
    Giusti, G., Gondii, P., Borreli, D., Fiorelli, G., Forti, G., Pazzagli, M., and Serio, M., 1975, Age-related secretion of androstenedione, testosterone, and dihydrotestosterone by the human testis, Exp. Gerontol. 10(5):241–245.PubMedGoogle Scholar
  211. 209.
    Pirke, K. M. and Doerr, P., 1975, Plasma dihydrotestosterone in normal adult males and its relation to testosterone, Acta Endocrinol. 79:357–365.PubMedGoogle Scholar
  212. 210.
    Sawin, C. T., Chopra, D., Azizi, F., Mannix, J. E., and Bacharach, P., 1979, The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly, JAMA 242(3):247–250.PubMedGoogle Scholar
  213. 211.
    Muta, K., Kato, K., Akamine, Y., and Ibayishi, H., 1981, Age related changes in the feedback regulation of gonadotropin secretion by sex steroids in men, Acta Endocrinol. 96:154–162.PubMedGoogle Scholar
  214. 212.
    Snyder, P. J., Reitano, J. F., and Utiger, R. D., 1975, Serum LH and FSH responses to synthetic gonadotrophin releasing hormone in normal men, J. Clin. Endocrinol. Metab. 41(5):938–945.PubMedGoogle Scholar
  215. 213.
    Hang, E. A., Aakvaag, A., Sand, T., and Torjesen, P. A., 1974, The gonadotrophin response to synthetic GnRH in males in relation to age, dose, and basal serum levels of estradiol-17 and gonadotrophins, Acta Endocrinol. 77(4):625–635.Google Scholar
  216. 214.
    Harman, S. M., Tsitouras, P. D., Costa, P. T., Loriaux, D. L., and Sherins, R. J., 1982, Evaluation of pituitary gonadotropic function in men: Value of luteinizing hormone-releasing hormone response versus basal luteinizing hormone level for discrimination of diagnosis, J. Clin. Endocrinol. Metab. 54:196–200.PubMedGoogle Scholar
  217. 215.
    Gordon, G. G., Altman, K., Southern, A. L., Rubin, E., and Lieber, C. S., 1976, Effects of alcohol on sex-hormone metabolism in normal men, N. Engl. J. Med. 295:793–797.PubMedGoogle Scholar
  218. 216.
    Turner, T. B., Mezey, E., and Kimball, A. W., 1977, Measurement of alcohol-related effects in man: Chronic effects in relation to level of alcohol consumption, Johns Hopkins Med. J. 141:235–248.PubMedGoogle Scholar
  219. 217.
    Michael, R. P. and Zympe, D., 1978, Potency in male rhesus monkeys: Effect of continuously receptive females, Science 200:451–453.PubMedGoogle Scholar
  220. 218.
    Martin, C. E., 1981, Factors affecting sexual functioning in 60 to 79 year old married males, Arch. Sex. Behav. 5:399–420.Google Scholar
  221. 219.
    Kent, J. Z. and Acone, A. B., 1966, Plasma androgens and aging, in: Androgens in Normal and Pathological Conditions (A. Vermeulen and D. Exley, eds.), Excerpta Medica Foundation ICS #101, Amsterdam, pp. 31–40.Google Scholar
  222. 220.
    Wesson, M. B., 1964, The value of testosterone in men past middle age, J. Am. Geriatr. Soc. 12:1149–1153.PubMedGoogle Scholar
  223. 221.
    Reiter, T., 1963, Testosterone implantation: A clinical study of 240 implantations in aging males, J. Am. Geriatr. Soc. 11:540–550.PubMedGoogle Scholar
  224. 222.
    Vaughn, T. C. and Hammond, C. B., 1981, Estrogen replacement therapy, Clin. Obstet. Gynecol. 24(l):253–283.PubMedGoogle Scholar
  225. 223.
    Notelovitz, M., 1978, Gynecologic problems of menopausal women. I. Changes in genital tissue, Geriatrics 33(8):24–30.PubMedGoogle Scholar
  226. 224.
    Quigley, M. M. and Hammond, C. B., 1979, Estrogen-replacement therapy: Help or hazard? N. Engl. J. Med. 301:646–648.PubMedGoogle Scholar
  227. 225.
    Jaffe, R. B., 1978, The menopause and perimenopausal period, in: Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management (S. S. C. Yen and R. B. Jaffe, eds.), W. B. Saunders, Philadelphia, pp. 261–270.Google Scholar
  228. 226.
    Jaszmann, L. J. B., 1976, Epidemiology of the climacteric syndrome, in: The Management of the Menopause and Post-Menopausal Years (S. Campbell, ed.), University Park Press, Baltimore, pp. 11–23.Google Scholar
  229. 227.
    Gregerman, R. I. and Bierman, E. L., 1981, Aging and hormones, in: Textbook of Endocrinology (R. H. Williams, ed.), W. B. Saunders, Philadelphia, pp. 1192 – 1209.Google Scholar
  230. 228.
    Sherman, B. M. and Korenman, S. G., 1975, Hormonal characteristics of the human menstrual cycle throughout reproductive life, J. Clin. Invest. 55:699–706.PubMedGoogle Scholar
  231. 229.
    Sherman, B. M., West, J. H., and Korenman, S. J., 1976, The menopausal transition: Analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women, J. Clin. Endocrinol. Metab. 42:629–636.PubMedGoogle Scholar
  232. 230.
    Muta, K., Kato, K., Akamine, Y., and Ibayishi, H., 1981, Age related changes in the feedback regulation of gonadotropin secretion by sex steroids in men, Acta Endocrinol. 96:154–162.PubMedGoogle Scholar
  233. 231.
    Geola, F. L., Frimar, A. M., Tataryn, I. V., Lu, K. H., Hershman, J. M., Eggena, P., Sambhi, M. P., and Judd, H. L., 1980, Biological effects of various doses of equine conjugated estrogens in postmenopausal women, J. Clin. Endocrinol. Metab. 51:620–625.PubMedGoogle Scholar
  234. 232.
    Yen, S. S. C., Tsai, C. C., Naftolin, F., Vandenburg, G., and Ajabor, L., 1972, Pulsatile patterns of gonadotropin release in subjects with and without ovarian function, J. Clin. Endocrinol. Metab. 34:671–675.PubMedGoogle Scholar
  235. 233.
    Silver, T. M. and Yen, S. S. C., 1973, Augmented gonadotropin response to synthetic LRF in hypogonadal state, J. Clin. Endocrinol. Metab. 37:491–494.Google Scholar
  236. 234.
    Harman, S. M. and Tsitouras, P. D., 1980, Reproductive hormones in aging men. I. Measurement of sex steroids, basal LH and Leydig cell response to hCG, J. Clin. Endocrinol. Metab. 51:35–40.PubMedGoogle Scholar
  237. 235.
    Hutton, J. D., Jacobs, H. S., and James, V. H. T., 1979, Steroid endocrinology after the menopause: A review, J. R. Soc. Med. 72(11):835–841.PubMedGoogle Scholar
  238. 236.
    Judd, H. L., 1976, Hormonal dynamics associated with the menopause, Clin. Obstet. Gynecol. 19:775–788.PubMedGoogle Scholar
  239. 237.
    Judd, H. L., 1980, Reproductive hormone metabolism in postmenopausal women, in: Menopause, Comprehensive Management (B. A. Eskin, ed.), Masson Publishing Co., New York, pp. 55–71.Google Scholar
  240. 238.
    Aksel, S., Schomberg, D. W., Tyrey, L., and Hammond, C. B., 1976, Vasomotor symptoms, serum estrogens and gonadotropin levels in surgical menopause, Am. J. Obstet. Gynecol. 126:165–169.PubMedGoogle Scholar
  241. 239.
    Grodin, J. M., Siiteri, P. K., and MacDonald, B. C., 1973, Source of estrogen production in postmenopausal women, J. Clin. Endocrinol. Metab. 36:207–214.PubMedGoogle Scholar
  242. 240.
    Elahi, D., Muler, D., Tzankoff, S., Andres, R., and Tobin, J. D., 1978, Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and GH, The Ger-ontologist 18(part 2):68 (Abstract).Google Scholar
  243. 241.
    Thompson, J. and Oswald, I., 1977, Effect of estrogen on the sleep, mood and anxiety of menopausal women, Br. Med. J. 2:1317–1319.Google Scholar
  244. 242.
    Yen, S. S. C., 1977, The biology of menopause, J. Reprod. Med. 18:287–296.PubMedGoogle Scholar
  245. 243.
    Aitken, J. M., Davidson, A., and England, P., 1974, The relationship between menopausal vasomotor symptoms and gonadotropin excretion in urine after oophorectomy, J. Obstet. Gynaecol. Br. Commonw. 81:150–154.PubMedGoogle Scholar
  246. 244.
    Meldrum, D. R., Erlik, Y., Lu, J. K. H., and Judd, H. L., 1981, Objectively recorded hot flushes in patients with pituitary insufficiency, J. Clin. Endocrinol. Metab. 52:684–689.PubMedGoogle Scholar
  247. 245.
    Meldrum, D. R., Tataryn, I. V., Frumar, A. M., Erlik, Y., Lu, K. H., and Judd, H., 1980, Gonadotropins, estrogens and adrenal steroids during the menopausal hot flash, J. Clin. Endocrinol Metab. 50:685–689.PubMedGoogle Scholar
  248. 246.
    Casper, R. F., Yen, S. S. C., and Wilkes, M. M., 1979, Menopausal flushes: A neuroendocrine link with pulsatile luteinizing hormone secretion, Science 205:823–825.PubMedGoogle Scholar
  249. 247.
    Albrecht, B. H., Schiff, L, Tulchinsky, D., and Ryan, K. J., 1981, Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flashes, Am. J. Obstet. Gynecol. 139:631–635.PubMedGoogle Scholar
  250. 248.
    Clayden, J. R., Bell, J. W., and Pollard, P., 1974, Menopausal flushing: Double-blind trial of a nonhormonal medication, Br. Med. J. 1(9 March):409–412.PubMedGoogle Scholar
  251. 249.
    Worley, R. J., 1981, Age, estrogen and bone density, Clin. Obstet. Gynecol. 24(1):203–218.PubMedGoogle Scholar
  252. 250.
    Johnson, R. E. and Specht, E. E., 1981, The risk of hip fracture in postmenopausal females with and without estrogen drug exposure, Am. J. Pub. Health 71:138–144.Google Scholar
  253. 251.
    Christiansen, C., Christensen, M. S., and Transbol, I., 1981, Bone mass in postmenopausal women after withdrawal of estrogen-gestagen replacement therapy, Lancet i:459–461.Google Scholar
  254. 252.
    Nordin, B. E. C., Horsman, A., Crilly, R. J., Marshall, D. H., and Simpson, M., 1980, Treatment of spinalosteoporosis in postmenopausal women, Br. Med. J. 280(6212):451–455.PubMedGoogle Scholar
  255. 253.
    Masters, W. H. and Johnson, V. E., 1970, Human Sexual Inadequacy, Little, Brown and Co., Boston.Google Scholar
  256. 254.
    Maoz, B. and Durst, N., 1980, The effects of estrogen therapy on the sex life of postmenopausal women, Maturitas 2:327–336.PubMedGoogle Scholar
  257. 255.
    Deutsch, S., Ossowski, R., and Benjamin, I., 1981, Comparison between degree of systemic absorption of vaginally and orally administered estrogens at different dose levels in postmenopausal women, Am. J. Obstet. Gynecol. 139:967–968.PubMedGoogle Scholar
  258. 256.
    Schiff, I., Tulchinsky, D., Ryan, K. J., Kadner, S., and Levitz, M., 1980, Plasma estriol and its conjugates following oral and vaginal adminstration of estriol to postmenopausal women: Correlations with gonadotropin levels, Am. J. Obstet. Gynecol. 138:1137–1141.PubMedGoogle Scholar
  259. 257.
    Keller, T. J., Riedmann, R., and Fischer, M., 1980, Ostron-Ostradiol-und Ostriolgehart nach intravaginaler Applikation von Ostriol in der Postmenopause, Gynaek. Rundsch. 20(Suppl 1):77–79.Google Scholar
  260. 258.
    Oliver, M. F., 1976, The menopause and coronary heart disease, in: The Management oj the Menopause and Postmenopausal Years (S. Campbell, ed.), University Park Press, Baltimore.Google Scholar
  261. 259.
    Ryan, K. J., 1976, Estrogen and atherosclerosis, Clin. Obstet. Gynecol. 19:805–815.PubMedGoogle Scholar
  262. 260.
    Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., and Beckman, E. M., 1979, Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma, cardiovascular and metabolic problems, Obstet. Gynecol. 54:74–79.PubMedGoogle Scholar
  263. 261.
    Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T., and Chapman, J. M., 1978, Coronary risk and estrogen use in postmenopausal women, Am. J. Epidemiol. 107:479–487.PubMedGoogle Scholar
  264. 262.
    Hammond, C. B., Jelovsek, F. R., Lee, K. L., Greasman, W. T., and Parker, R. T., 1979, Effects of long-term estrogen replacement therapy: I. Metabolic effects, Am. J. Obstet. Gynecol. 133:525–536.PubMedGoogle Scholar
  265. 263.
    Cordon, T., Kannel, W. B., Hjortland, M. C., and McNamara, P. M., 1978, Menopause and coronary heart disease. The Framingham Study, Ann. Intern. Med. 89:157–161.Google Scholar
  266. 264.
    The Coronary Drug Research Group, 1973, The coronary drug project, JAMA 226(6):652–657.Google Scholar
  267. 265.
    Tikkanen, M. J., Kuusi, T., Vartiainen, E., and Nikkila, E. A., 1979, Treatment of post-menopausal hypercholesterolemia with estradiol, Acta Obstet. Gynecol. Scand., 88(Suppl.):83–88.Google Scholar
  268. 266.
    Varma, T. R., 1980, Effect of estrogen on fasting serum cholesterol and triglyceride levels in post-menopausal women, Int. J. Gyneacol. Obstet. 17:551–555.Google Scholar
  269. 267.
    Largelius, A., Johnson, P., Lunell, N.-O., and Samsioe, G., 1981, Treatment with oral estrone sulfate in the female climacteric. I. Influence on lipids, Acta Obstet. Gynecol. Scand. 60:27–31.Google Scholar
  270. 268.
    Silfverstolpe, G., Gustafson, A., Samsioe, G., and Svanborg, A., 1979, Lipid metabolic studies in oophorectomized women, Acta Obstet. Gyneacol. Scand. 88(Suppl.):89–95.Google Scholar
  271. 269.
    Krauss, R. M., Lindgren, F. T., Wingerd, J., Bradley, D. D., and Ramcharan, S., 1979, Effects of estrogens and progestins on high density lipoproteins, Lipids 14:114–118.Google Scholar
  272. 270.
    Lillienberg, L., Adlercreutz, H., and Svanborg, A., 1979, Effect of a sequential estrogen-progestin therapy on the plasma level of estrogens and lipids on postmenopausal women, Acta Endocrinol. 92:319–329.PubMedGoogle Scholar
  273. 271.
    Paterson, M. E. L., Sturdee, D. W., Moore, B., and Whitehead, T. P., 1980, The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentration in post-menopausal women, Br. J. Obstet. Gynecol. 87:552–560.Google Scholar
  274. 272.
    Hirvonen, E., Malkomen, M., and Manninen, D., 1981, Effects of different progestogens on lipoproteins during post-menopausal replacement therapy, N. Engl. J. Med. 304:560–563.PubMedGoogle Scholar
  275. 273.
    Bland, K. I., Buchanan, J. B., Weisberg, B. F., Hagan, T., and Grey, L. A., 1980, The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns, Cancer 45:3027–3033.PubMedGoogle Scholar
  276. 274.
    Gambrell, R. D., Massey, F. M., Castaneda, T. A., and Boddie, A., 1980, Estrogen therapy and breast cancer in postmenopausal women, J. Am. Geriatr. Soc. 28:251–257.PubMedGoogle Scholar
  277. 275.
    Ziel, H. K. and Finkle, W. D., 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N. Engl. J. Med. 293:1167–1170.PubMedGoogle Scholar
  278. 276.
    Smith, D. C., Prentice, R., Thompson, D. J., and Hermann, W. L., 1975, Association of exogenous estrogen and endometrial carcinoma, N. Engl. J. Med. 293:1164–1166.PubMedGoogle Scholar
  279. 277.
    McDonald, T. W., Annegers, J. F., O’Fallon, W. M., Dockerty, M. B., Malkasian, G. D., and Kurlan, L. T., 1977, Exogenous estrogen and endometrial carcinoma. Case-control and incidence study, Am. J. Obstet. Gynecol. 127:572–580.PubMedGoogle Scholar
  280. 278.
    Weiss, N. S., Szekely, D. R., and Austin, D. F., 1976, Increasing incidence of endometrial cancer in the United States, N. Engl. J. Med. 294:1259–1262.PubMedGoogle Scholar
  281. 279.
    Gardner, W. V., 1944, Tumors in experimental animals receiving steroid hormones, Surgery 6:8–32.Google Scholar
  282. 280.
    Perry, I. H. and Ginzton, L. L., 1937, Development of tumors in female mice treated with 1,2,5,6-dibenzanthracene and theelin, Am. J. Cancer 29:680–704.Google Scholar
  283. 281.
    Cook, J. W. and Dodds, E. C., 1933, Sex hormones and cancer producing compounds, Nature (London) 131:205–206.Google Scholar
  284. 282.
    Mack, T. M., 1978, Exogenous estrogens and endometrial carcinoma: Studies, Criticisms and Current Status, in: International Symposium on Endometrial Cancer (M. G. Brush, R. J. King, and R. Taylor, eds.), Bailliere Tindall, London, pp. 17–28.Google Scholar
  285. 283.
    Klopper, A., 1980, The risk of endometrial carcinoma from estrogen therapy of the menopause, Acta Endocrinol. 233 (Suppl.):29–35.Google Scholar
  286. 284.
    Salini, T., 1980, Endometrial carcinoma risk factors with special reference to the use of estrogens, Acta Endocrinol. 233(Suppl.):37–43.Google Scholar
  287. 285.
    Volker, W., Kannengiesser, U., Majewski, A., and Vasterling, H. W., 1978, Ostrogentherapie und Endometriumkarzinom, Geburtschilfe Frauenheilkd. 38:735–743.Google Scholar
  288. 286.
    Hulka, B. S., Kaufman, D. G., Fowler, W. C., Grimson, R. C., and Greenberg, B. G., 1980, Predominance of early endometrial cancers after long-term estrogen use, JAMA 244:2419–2422.PubMedGoogle Scholar
  289. 287.
    Paterson, M. E. L., Wade-Evans, T., Sturdee, D. W., Thorn, M. H., and Studd, J. W. W., 1980, Endometrial disease after treatment with estrogens and progestogens in the climacteric, Br. Med. J. 1 (March):822–824.Google Scholar
  290. 288.
    King, R. J. B., Whitehead, M. I., Campbell, S., and Minardi, J., 1979, Effect of estrogen and progestin treatments on endometria from post-menopausal women, Cancer Res. 39:1094–1101.PubMedGoogle Scholar
  291. 289.
    Gambrell, R. D., Massey, F. M., and Castameda, T. A., 1979, Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens, J. Am. Geriatr. Soc. 27:389–394.PubMedGoogle Scholar
  292. 290.
    Thorn, M. H., White, P. J., Williams, R. M., Sturdee, D. W., Paterson, M. E. L., Wade-Evans, T., and Studd, J. W. W., 1979, Prevention and treatment of endometrial disease in climacteric women receiving estrogen therapy, Lancet ii:455–457.Google Scholar
  293. 291.
    Aiman, J., 1981, Age, estrogen, and the endometrium, Clin. Obstet. Gynecol. 24:193–202.PubMedGoogle Scholar
  294. 292.
    Studd, J. W. W., Thorn, M., Dische, F., Driver, M., Wade-Evans, T., and Williams, D., 1979, Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy, Br. Med. J. 280(6167):846–848.Google Scholar
  295. 293.
    Estrogen use and postmenopausal women, 1979, Ann. Intern. Med. 91:921–922.Google Scholar
  296. 294.
    Estrogen use and postmenopausal women, 1979, National Institutes of Health Consensus Development Conference, Vol. 2, No. 8, NIH, Bethesda, MD.Google Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • Uriel S. Barzel
    • 1
  • Steven R. Gambert
    • 2
    • 3
    • 4
    • 5
  • Panayiotis D. Tsitouras
    • 6
    • 4
  1. 1.Endocrine Section, Department of Medicine, Montefiore Hospital and Medical CenterAlbert Einstein College of MedicineBronxUSA
  2. 2.Section of Geriatrics and Gerontology, Department of MedicineThe Medical College of WisconsinMilwaukeeUSA
  3. 3.Milwaukee Long-Term Care Gerontology CenterMilwaukeeUSA
  4. 4.Geriatrics Section, Medical ServiceWood Veterans Administration Medical CenterWoodUSA
  5. 5.Geriatrics ServiceMilwaukee County Medical ComplexMilwaukeeUSA
  6. 6.Sections of Geriatrics and Gerontology and of Endocrinology, Department of MedicineThe Medical College of WisconsinMilwaukeeUSA

Personalised recommendations